Macroaxis: Personalized Investing

Personalized Investing and

Digital Wealth Optimization

GILD    AMGN    BIIB    CELG    Benchmark  United States  NYSE  10,875   9.9912 Index Moved Up 0.092%  


Processing
Collecting data for STEM

StemCells Inc  

    
$0.988
Change

0.01

  

1.33%

Year To Date
0.842.43
Last 1 Month(s)
0.981.38
10 Days Price Trend
March 28, 2015 
Highest Price  
Lowest Price  
March 3, 2015 
March 25, 2015 

StemCells Market Sensitivity

As returns on market increase, StemCells returns are expected to increase less than the market. However during bear market, the loss on holding StemCells will be expected to be smaller as well.

StemCells Inc Market Cap Over Time

SymbolSTEM
ISINUS085857R200
CUSIP085857R20
NameStemCells Inc
InstrumentUSA Stock
SectorHealthcare
IndustryBiotechnology
BenchmarkNYSE
Webhttp://www.stemcellsinc.com
Contact Number510. 456. 4000
CurrencyUSD - US Dollar
ExchangeNasdaq Capital Markets
 
Return On Asset(51.65) %
Price to Book5.33 times
Price to Sales72.04 times

StemCells agains markets

 thisGreen STEM STEM agains markets  1.33 % Macroaxis: change 1.333 Moved Up  
 
 United States Russel   0.68 % Macroaxis: 0.6834 Moved Up  
 
 United States Nasdaq   0.57 % Macroaxis: 0.57 Moved Up  
 
 United States SP 500   0.24 % Macroaxis: 0.24 Moved Up  
 
 United States NYSE   0.09 % Macroaxis: 0.092 Moved Up  
 
Compare to Competition   Compare Correlations

StemCells Leadership

Martin McGlynn CEO and President Director, Member of Strategic Transactions Committee, CEO of StemCells California Inc and President of StemCells California Inc
John Schwartz Independent Chairman of the Board, Ph.D

StemCells Diversification Suggestion

Use StemCells to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of StemCells to be traded at $1.0868 in 30 days

StemCells Price and Market Media

The median price of StemCells for the period between Thu, Feb 26, 2015 and Sat, Mar 28, 2015 is 1.12 with a coefficient of variation of 10.4. The daily time series for the period is distributed with a sample standard deviation of 0.12, arithmetic mean of 1.13, and mean deviation of 0.1. The Stock received some media coverage during the period.
StemCells Value 
Benchmark  Embed   Timeline 
1
StemCells Inc. Appoints Ian Massey as President and Chief Op...03/24/2015

StemCells Summary

StemCells Inc [STEM] is traded on Nasdaq Capital Markets in USA. It is located in Newark, CA and employs 58 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 82.47 M. StemCells Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 68.73 M outstanding shares of which 1.8 M shares are at this time shorted by private and institutional investors with about 4.6 trading days to cover.
StemCells, Inc., a biopharmaceutical company, is engaged in the research, development, and commercialization of stem cell therapeutics, and related tools and technologies for stem cellbased research and drug discovery and development. more

StemCells Inc Accumulated Other Comprehensive Income Over Time

StemCells Alerts

StemCells Inc generates negative expected return over the last 30 days
StemCells Inc has high historical volatility and very poor performance
StemCells Inc has some characteristics of a very speculative penny stock
StemCells Inc has high likelihood to experience some financial distress in the next 2 years
The company reported previous year revenue of 1.16 M. Net Loss for the year was (29.46 M) with profit before overhead, payroll, taxes, and interest of 886.64 K.
STEMCELLS INC currently holds about 32.21 M in cash with (27.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47.
Roughly 24.0% of the company outstanding shares are owned by corporate insiders
Latest headline from www.marketwatch.com: StemCells Inc. Appoints Ian Massey as President and Chief Operating Officer

StemCells Earnings Estimates

StemCells Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
StemCells Earnings Estimate  

StemCells Research Report

Get StemCells research report. Reports are available in pdf format and contain fundamental information about the equity. Click Generate StemCells report to view

StemCells Pair Trading Analysis

Correlation analysis and pair trading evaluation for StemCells and Gilead Sciences. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run pair correlation  

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Macroaxis investing theme could easily outperform a given market if properly optimized
Explore Investing Ideas  

StemCells Directors

Irving Weissman Director
Eric Bjerkholt Independent Director
R Greer Independent Director
Ricardo Levy Independent Director
Alan Trounson Director

StemCells Fundamentals Correlation

Price to Sales vs Short Ratio
Revenue vs Current Valuation
Price to Sales vs Total Asset

StemCells vs Competition

StemCells vs. Gilead Sciences Inc
StemCells vs. Amgen Inc
StemCells vs. Biogen Idec Inc
StemCells vs. Celgene Corporation
StemCells vs. Regeneron Pharmaceuticals Inc
StemCells vs. Alexion Pharmaceuticals Inc
StemCells vs. Vertex Pharmaceuticals Incorporated
StemCells vs. Illumina Inc
StemCells vs. Pharmacyclics Inc
StemCells vs. BioMarin Pharmaceutical Inc

StemCells March 28, 2015 Opportunity Range

Information Ratio(0.04)
Maximum Drawdown35.61
Value At Risk(10.14)